Hayat Pharmaceutical Industries Co (AMM:HPIC) OCF Margin %: 47.65% (As of Mar. 2026) — 147% Above Median


AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
79 GF Score
Price JOD3.12
GF Value JOD2.74
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co OCF Margin %?

Hayat Pharmaceutical Industries Co AMM:HPIC 79 OCF Margin % is 47.65% as of Mar. 2026, which is 147% above its 10-year median of 19.30. GuruFocus rates AMM:HPIC with a GF Score™ of 79/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 959 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks better than 93.64% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Hayat Pharmaceutical Industries Co's Cash Flow from Operations for the three months ended in Mar. 2026 was JOD0.96 Mil. Hayat Pharmaceutical Industries Co's Revenue for the three months ended in Mar. 2026 was JOD2.02 Mil. Therefore, Hayat Pharmaceutical Industries Co's OCF Margin % for the quarter that ended in Mar. 2026 was 47.65%.

As of today, Hayat Pharmaceutical Industries Co's current OCF Yield % is 17.34%.

The historical rank and industry rank for Hayat Pharmaceutical Industries Co's OCF Margin % or its related term are showing as below:

AMM:HPIC' s OCF Margin % Range Over the Past 10 Years
Min: 16.4   Med: 19.3   Max: 33.36
Current: 31.51


During the past 13 years, the highest OCF Margin % of Hayat Pharmaceutical Industries Co was 33.36%. The lowest was 16.40%. And the median was 19.30%.

AMM:HPIC's OCF Margin % is ranked better than
93.64% of 959 companies
in the Drug Manufacturers industry
Industry Median: 9.95 vs AMM:HPIC: 31.51


Hayat Pharmaceutical Industries Co OCF Margin % Related Terms


Hayat Pharmaceutical Industries Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co OCF Margin % Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.36 18.18 17.60 19.64 20.91

Hayat Pharmaceutical Industries Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.33 70.75 3.34 30.75 47.65

AMM:HPIC vs ZTS, UTHR, VTRS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hayat Pharmaceutical Industries Co OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Hayat Pharmaceutical Industries Co's OCF Margin % falls into.


AMM:HPIC
79GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hayat Pharmaceutical Industries Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Hayat Pharmaceutical Industries Co's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=3.578/17.108
=20.91 %

Hayat Pharmaceutical Industries Co's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0.963/2.021
=47.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 47.65% mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a OCF Margin % of 47.65% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hayat Pharmaceutical Industries Co and its competitors. This is 147% above median its historical median of 19.30. Over the past decade, Hayat Pharmaceutical Industries Co's OCF Margin % has ranged from 16.40 to 33.36. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #61 out of 959 companies in the Drug Manufacturers industry, placing it in the top 6.4%.
Is Hayat Pharmaceutical Industries Co's OCF Margin % too high?
Hayat Pharmaceutical Industries Co's current OCF Margin % of 47.65% is 147% above median its 10-year median of 19.30. Over the past 10 years, this metric has ranged from a low of 16.40 to a high of 33.36. The Drug Manufacturers industry median OCF Margin % is 9.95. Hayat Pharmaceutical Industries Co's value of 47.65% is 378.9% above this industry median. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #61 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #61 out of 959 companies for OCF Margin %. This places Hayat Pharmaceutical Industries Co in the top 6% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Hayat Pharmaceutical Industries Co's value of 47.65% is 378.9% above this benchmark. Historically, Hayat Pharmaceutical Industries Co's own OCF Margin % has ranged from 16.40 to 33.36 over the past decade. While the company's 10-year median is 19.30 vs. the industry median of 9.95, Hayat Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hayat Pharmaceutical Industries Co's current OCF Margin % of 47.65% is 378.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current OCF Margin % is 47.65%, which is 147% above median its own 10-year median of 19.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.12 — trading 13.9% above its estimated fair value. The current OCF Margin % is 47.65%, which is 147% above median its 10-year median of 19.30 and 378.9% above the Drug Manufacturers industry median of 9.95. Hayat Pharmaceutical Industries Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current OCF Margin % is 47.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?

Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued. The current stock price of JOD3.12 is trading 13.9% above its estimated GF Value™ of JOD2.74. GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.

Key valuation signals for AMM:HPIC:

  • OCF Margin %: 47.65% (147% above median its 10-year median of 19.30)
  • GF Value™: JOD2.74 vs. price of JOD3.12 (13.9% above fair value)
  • GF Score™: 79/100 with 6 warning signs
  • Industry Position: 378.9% above the Drug Manufacturers median (#61 of 959)

No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
79GF Score

Get the complete analysis for AMM:HPIC

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.12
Price
JOD2.74
GF Value